Insider · CIK 0001601078
Gili Iohan
Files at VRNS (VARONIS SYSTEMS INC), FVRR (Fiverr International Ltd.). First filing -, latest -.
Gili Iohan files SEC Form 4 as director at VRNS (VARONIS SYSTEMS INC), and also at FVRR (Fiverr International Ltd.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Gili Iohan has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Apr 30, 2026 | VRNS VARONIS SYSTEMS INC | AGrant or award Common Stock, par value $0.001 per share | +7,224 | $0.00 | $0 | 34,828 | May 1, 2026 |
| Apr 23, 2026 | FVRR Fiverr International Ltd. | AGrant or award Ordinary Shares | +21,718 | $0.00 | $0 | 42,112 | Apr 27, 2026 |
| May 8, 2025 | VRNS VARONIS SYSTEMS INC | AGrant or award Common Stock, par value $0.001 per share | +4,178 | $0.00 | $0 | 27,604 | May 9, 2025 |
Questions about Gili Iohan
Answered from the filings on this page, as of the latest one.
Is Gili Iohan buying or selling?
Gili Iohan has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Gili Iohan's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Gili Iohan has 0.
Where does Gili Iohan file Form 4?
Gili Iohan has filed Form 4 at VRNS (VARONIS SYSTEMS INC); FVRR (Fiverr International Ltd.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.